Best Biotech Stocks

Gilead (GILD), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) are some of the most trending stocks in the biotech sector. See how they compare to other companies such as Biogen (BIIB), Illumina (ILMN) and Regeneron (REGN).

Compare up to 10 stocks

Biotech Stocks

Comparison Ideas 5g Stocks Adtech Stocks Aerospace and Defense Stocks Airline Stocks Artificial Intelligence Stocks Bank Stocks Beer & Beverage Stocks Biotech Stocks Bitcoin Stocks Blockchain Stocks Blue Chip Stocks Cannabis Stocks Casino Stocks ChatGPT Stocks Chinese Stocks Chip Stocks Cloud & Storage Stocks Cryptocurrency Stocks Cybersecurity Stocks Dividend Stocks Electric Vehicle Stocks Energy Stocks FAANG Stocks Gold Stocks Green Energy Stocks Green Hydrogen Stocks Growth Stocks Healthcare Stocks Hotel Stocks Japanese Stocks Large Cap Stocks Magnificent 7 Stocks Mega Cap Stocks Meme Stocks Metaverse Stocks Nuclear Stocks Oil Stocks OpenAI Stocks Quantum Computing Stocks Social Media Stocks Solar Stocks Tech Stocks Trump Tariffs: Stocks at Risk in 2025 Trump Tariffs: Stocks That Could Benefit in 2025 Utility Stocks Value Stocks Virtual Reality Stocks WallStreetBets Stocks

RESET ALL

GILD AMGN VRTX BIIB ILMN REGN MRNA IQV BNTX

Biotech Stocks

Comparison Results

Biotech Stocks

Name	Price	Volume	Analyst Price Target	Analyst Consensus	Market Cap	P/E Ratio	Dividend Yield	Sector
GILD	$103.19	11.29M	xxxxxxxxxxxxx	17 Buy 6 Hold 0 Sell Moderate Buy	$133.70B	280.39	2.89%	Healthcare
AMGN	$280.26	4.10M	xxxxxxxxxxxxx	11 Buy 6 Hold 1 Sell Moderate Buy	$158.15B	38.94	3.10%	Healthcare
VRTX	$472.37	2.39M	xxxxxxxxxxxxx	16 Buy 10 Hold 1 Sell Moderate Buy	$122.02B	-215.54	―	Healthcare
BIIB	$114.05	2.09M	xxxxxxxxxxxxx	13 Buy 13 Hold 0 Sell Moderate Buy	$18.00B	10.66	―	Healthcare
ILMN	$70.30	3.21M	xxxxxxxxxxxxx	9 Buy 8 Hold 2 Sell Moderate Buy	$11.75B	-9.51	―	Healthcare
REGN	$556.81	1.16M	xxxxxxxxxxxxx	16 Buy 3 Hold 1 Sell Strong Buy	$62.69B	14.96	0.15%	Healthcare
MRNA	$24.64	8.95M	xxxxxxxxxxxxx	3 Buy 11 Hold 4 Sell Hold	$9.69B	-2.76	―	Healthcare
IQV	$144.49	2.70M	xxxxxxxxxxxxx	12 Buy 3 Hold 0 Sell Strong Buy	$27.28B	20.41	―	Healthcare
BNTX	$86.65	951.63K	xxxxxxxxxxxxx	14 Buy 3 Hold 0 Sell Strong Buy	$21.13B	-28.76	―	Healthcare

Performance Comparison

GILD

Gilead Sciences

105.52

38.61

57.70%

AMGN

Amgen

289.69

28.45

10.89%

VRTX

Vertex Pharmaceuticals

474.56

70.34

17.40%

BIIB

Biogen

119.19

-85.76

-41.84%

ILMN

Illumina

73.45

-53.01

-41.92%

REGN

Regeneron

572.78

-364.50

-38.89%

MRNA

Moderna

25.64

-79.45

-75.60%

IQV

IQVIA Holdings

153.01

-88.49

-36.64%

BNTX

BioNTech SE

86.82

-2.49

-2.79%

Biotech Latest News

Illumina price target lowered to $112 from $128 at RBC Capital

RBC Capital analyst Conor McNamara lowered the firm’s price target on Illumina (ILMN) to $112 from $128 and...

12h ago

ILMN

VOO ETF News, 4/8/2025

unc ...

15h ago

Vertex Pharmaceuticals announces EC approval of expanded KAFTRIO label

Vertex Pharmaceuticals (VRTX) announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO...

1d ago

VRTX

Unusually active option classes on open April 7th

Unusual total active option classes on open include: Universal Health (UHS), Goodyear Tire (GT), Rocket Companies (RKT), B2Gold...

1d ago

Optimistic Growth Prospects for Gilead Sciences: Buy Rating Backed by HIV and Oncology Advancements

Analyst Chris Schott from J.P. Morgan maintained a Buy rating on Gilead Sciences (GILD – Research Report) and...

2d ago

GILD

Illumina price target lowered to $85 from $90 at Citi

Citi lowered the firm’s price target on Illumina (ILMN) to $85 from $90 and keeps a Neutral rating...

2d ago

ILMN

Moderna to Present Extensive Infectious Disease Research at ESCMID 2025

Moderna ( ($MRNA) ) just unveiled an update. Moderna announced its participation in the ESCMID 2025 Global Congress...

2d ago

MRNA

BioNTech SE Announces Virtual Annual General Meeting for 2025

BioNTech SE ( ($BNTX) ) has shared an update. On April 4, 2025, BioNTech SE announced the invitation...

4d ago

BNTX

Early notable gainers among liquid option names on April 4th

Notable gainers among liquid option names this morning include MarketAxess (MKTX) $228.00 +11.85, Church & Dwight (CHD) $113.34...

4d ago

CHD

CLX

Biogen cut to Hold at Argus on expected earnings decline

As previously reported, Argus downgraded Biogen (BIIB) to Hold from Buy. The company has provided guidance for 2025,...

4d ago

BIIB

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Biotech Stocks

AMGN

Amgen

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2025-04-08

BIIB

Biogen

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2025-04-08

ILMN

Illumina

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2025-04-08

BNTX

BioNTech SE

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2025-04-07

GILD

Gilead Sciences

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2025-04-07

IQV

IQVIA Holdings

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2025-04-04

REGN

Regeneron

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2025-04-03

MRNA

Moderna

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2025-04-03

VRTX

Vertex Pharmaceuticals

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2025-04-02

ILMN

Illumina

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2025-04-07

All Ratings >

Most Recent Earnings of Biotech Stocks

GILD

Gilead Sciences

Feb 11, 2025

Dec 01, 2024

1.74 / 1.90

-1.32

AMGN

Amgen

Feb 04, 2025

Dec 01, 2024

5.09 / 5.31

3.96

VRTX

Vertex Pharmaceuticals

Feb 10, 2025

Dec 01, 2024

4.02 / 3.98

4.76

BIIB

Biogen

Feb 12, 2025

Dec 01, 2024

3.33 / 3.44

3.67

ILMN

Illumina

Feb 06, 2025

Dec 01, 2024

0.91 / 0.95

0.087

REGN

Regeneron

Feb 04, 2025

Dec 01, 2024

11.28 / 12.07

9.55

MRNA

Moderna

Feb 14, 2025

Dec 01, 2024

-2.68 / -2.91

-3.07

IQV

IQVIA Holdings

Feb 06, 2025

Dec 01, 2024

3.11 / 3.12

2.54

BNTX

BioNTech SE

Mar 10, 2025

Dec 01, 2024

0.49 / 1.18

-1.31

Biotech - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?

These Biotech stocks currently have a "Strong Buy" analyst rating consensus:

Regeneron - Strong Buy, based on 20 analyst ratings, 16 Buy, 3 Hold, and 1 Sell.

IQVIA Holdings - Strong Buy, based on 15 analyst ratings, 12 Buy, 3 Hold, and 0 Sell.

BioNTech SE - Strong Buy, based on 17 analyst ratings, 14 Buy, 3 Hold, and 0 Sell.

Are Biotech stocks overpriced?

Gilead Sciences's stock price is currently $103.19, and its average 12-month price target is $115.28.

Amgen's stock price is currently $280.26, and its average 12-month price target is $332.71.

Vertex Pharmaceuticals's stock price is currently $472.37, and its average 12-month price target is $499.09.

Biogen's stock price is currently $114.05, and its average 12-month price target is $192.24.

Illumina's stock price is currently $70.30, and its average 12-month price target is $125.65.

Regeneron's stock price is currently $556.81, and its average 12-month price target is $949.25.

Moderna's stock price is currently $24.64, and its average 12-month price target is $51.29.

IQVIA Holdings's stock price is currently $144.49, and its average 12-month price target is $241.25.

BioNTech SE's stock price is currently $86.65, and its average 12-month price target is $139.56.

Which Biotech stocks pay dividends?

Gilead Sciences does not currently pay dividends.

Amgen currently pays a dividend of $2.38 which represents an annual dividend yield of 3.10%. Amgen's next Ex-dividend date is May 16, 2025 and its next payout date is June 6, 2025.

Vertex Pharmaceuticals does not currently pay dividends.

Biogen does not currently pay dividends.

Illumina does not currently pay dividends.

Regeneron does not currently pay dividends.

Moderna does not currently pay dividends.

IQVIA Holdings does not currently pay dividends.

BioNTech SE does not currently pay dividends.